Primary Sjögren’s syndrome (SS) is a systemic autoimmune disorder characterised by the presence of serum autoantibodies directed to the ubiquitous intracellular autoantigens Ro (SS-A) and La (SS-B). 1 ...

Neuropsychological Performance in Survivors of Breast Cancer More Than 20 Years After Adjuvant Chemotherapy Two independent cohorts of patients with primary myelofibrosis (PMF) or myelodysplastic ...

We report an unusual histologic manifestation of light chain deposition disease in a 69-year-old female patient, who presented with nephrotic syndrome and an increased serum creatinine. The renal ...

Abbreviations: EFS, event-free survival; OS, overall survival; HR, hazard ratio; NCCTG, North Central Cancer Treatment Group; IPI, International Prognostic Index; MER ...

From (φ,ψ ) data for the middle amino acid, n, in the series of tripeptides (n - 1)(n)(n + 1) in six proteins whose three-dimensional structure is known from x-ray studies, (φ,ψ ) values for the ...

MINNEAPOLIS, May 10, 2023 /PRNewswire/ -- Bio-Techne (NASDAQ: TECH), a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic ...

When our plasma cells start producing a single cancer-causing protein rather than an array of antibody-like proteins to protect us, it's one of two arms of the Y-shaped protein that's likely to blame.

Company will combine mouse tech with YAC platform to generate human heavy chain drugs. U.K.-based Crescendo Biologics says it has developed a colony of triple-knockout mice that are totally lacking in ...

Researchers have validated a new antibody test to diagnose multiple sclerosis (MS), a potentially disabling disease of the brain and spinal cord. Mayo Clinic researchers have validated a new antibody ...

BOSTON & NEW YORK--(BUSINESS WIRE)--Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) and Caelum Biosciences today announced a collaboration to develop CAEL-101 for light chain (AL) amyloidosis. CAEL-101 ...

Mayo Clinic researchers have validated a new antibody test to diagnose multiple sclerosis (MS), a potentially disabling disease of the brain and spinal cord. Nearly 1 million people in the U.S. are ...